Advances in pulmonary delivery of nanoparticles

Gunjeet Kaur; R. K. Narang; Goutam Rath; Amit K. Goyal

doi:10.3109/10731199.2011.592494

Advances in pulmonary delivery of nanoparticles

Gunjeet Kaur, R. K. Narang, Goutam Rath, Amit K. Goyal

Research output: Contribution to journal › Article › peer-review

49 Scopus citations

Abstract

Nanotechnology has potential in the development of novel and effective delivery of drugs within lungs. Different strategies have been utilized for pulmonary delivery of drugs, including the use of lipid-based delivery systems (liposomes, ISCOMs, SLNs), use of polymeric matrix (PLGA, poly caprolactone, cynoacrylates, gelatin), development of polysaccharide particulates (chitosan, alginates, Carbopol, etc.), biocompatible metallic inorganic particles (iron, gold, zinc), etc. This paper reviews various nanopaticulate approaches in the form of lipids, polymers, metals, polysaccharides, or emulsions based for pulmonary drug delivery that could provide an increased biological efficacy and better local and systemic action. © 2012 Informa Healthcare USA, Inc.

Original language	English (US)
Pages (from-to)	75-96
Number of pages	22
Journal	Artificial Cells, Blood Substitutes, and Biotechnology
Volume	40
Issue number	1-2
DOIs	https://doi.org/10.3109/10731199.2011.592494
State	Published - Feb 1 2012
Externally published	Yes

Bibliographical note

Generated from Scopus record by KAUST IRTS on 2023-10-12

ASJC Scopus subject areas

Biomedical Engineering
Biotechnology

Access to Document

10.3109/10731199.2011.592494

Cite this

@article{764b30eac2b04a139770e46eec81b881,

title = "Advances in pulmonary delivery of nanoparticles",

abstract = "Nanotechnology has potential in the development of novel and effective delivery of drugs within lungs. Different strategies have been utilized for pulmonary delivery of drugs, including the use of lipid-based delivery systems (liposomes, ISCOMs, SLNs), use of polymeric matrix (PLGA, poly caprolactone, cynoacrylates, gelatin), development of polysaccharide particulates (chitosan, alginates, Carbopol, etc.), biocompatible metallic inorganic particles (iron, gold, zinc), etc. This paper reviews various nanopaticulate approaches in the form of lipids, polymers, metals, polysaccharides, or emulsions based for pulmonary drug delivery that could provide an increased biological efficacy and better local and systemic action. {\textcopyright} 2012 Informa Healthcare USA, Inc.",

author = "Gunjeet Kaur and Narang, {R. K.} and Goutam Rath and Goyal, {Amit K.}",

note = "Generated from Scopus record by KAUST IRTS on 2023-10-12",

year = "2012",

month = feb,

day = "1",

doi = "10.3109/10731199.2011.592494",

language = "English (US)",

volume = "40",

pages = "75--96",

journal = "Artificial Cells, Blood Substitutes, and Biotechnology",

issn = "1073-1199",

publisher = "Informa Healthcare",

number = "1-2",

}

TY - JOUR

T1 - Advances in pulmonary delivery of nanoparticles

AU - Kaur, Gunjeet

AU - Narang, R. K.

AU - Rath, Goutam

AU - Goyal, Amit K.

N1 - Generated from Scopus record by KAUST IRTS on 2023-10-12

PY - 2012/2/1

Y1 - 2012/2/1

N2 - Nanotechnology has potential in the development of novel and effective delivery of drugs within lungs. Different strategies have been utilized for pulmonary delivery of drugs, including the use of lipid-based delivery systems (liposomes, ISCOMs, SLNs), use of polymeric matrix (PLGA, poly caprolactone, cynoacrylates, gelatin), development of polysaccharide particulates (chitosan, alginates, Carbopol, etc.), biocompatible metallic inorganic particles (iron, gold, zinc), etc. This paper reviews various nanopaticulate approaches in the form of lipids, polymers, metals, polysaccharides, or emulsions based for pulmonary drug delivery that could provide an increased biological efficacy and better local and systemic action. © 2012 Informa Healthcare USA, Inc.

AB - Nanotechnology has potential in the development of novel and effective delivery of drugs within lungs. Different strategies have been utilized for pulmonary delivery of drugs, including the use of lipid-based delivery systems (liposomes, ISCOMs, SLNs), use of polymeric matrix (PLGA, poly caprolactone, cynoacrylates, gelatin), development of polysaccharide particulates (chitosan, alginates, Carbopol, etc.), biocompatible metallic inorganic particles (iron, gold, zinc), etc. This paper reviews various nanopaticulate approaches in the form of lipids, polymers, metals, polysaccharides, or emulsions based for pulmonary drug delivery that could provide an increased biological efficacy and better local and systemic action. © 2012 Informa Healthcare USA, Inc.

UR - http://www.tandfonline.com/doi/full/10.3109/10731199.2011.592494

UR - http://www.scopus.com/inward/record.url?scp=84856596401&partnerID=8YFLogxK

U2 - 10.3109/10731199.2011.592494

DO - 10.3109/10731199.2011.592494

M3 - Article

SN - 1073-1199

VL - 40

SP - 75

EP - 96

JO - Artificial Cells, Blood Substitutes, and Biotechnology

JF - Artificial Cells, Blood Substitutes, and Biotechnology

IS - 1-2

ER -

Advances in pulmonary delivery of nanoparticles

Abstract

Bibliographical note

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this